Patent ID: 11884636
Assignee: SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 6:
7. The method according to claim 5, wherein the gonadal hormone-related disease is selected from a group consisting of endometriosis, amenorrhea, menstrual irregularity, hysteromyoma, metrofibroma, polycystic ovarian disease, endometriosis, uterine leiomyoma, lupus erythematosus, hirsutism, precocious puberty, dwarfism, acne, alopecia, gonadotropin-dependent tumor, gonadotropin-producing pituitary adenomas, sleep apnea, irritable bowel syndrome, premenstrual syndrome, benign prostatic hyperplasia, contraception and infertility, and Alzheimer's disease.